Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2006 · 1.6K citations · Full text

Veterinary Medicine, Immunology, Oncology +16

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes

Karl Münger, William C. Phelps, Vivien J. Bubb et al. · Journal of Virology · 1989 · 1.3K citations · Full text

Life Sciences, Genetics, Molecular Biology +15

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Pamela Hawley‐Nelson, Karen H. Vousden, N L Hubbert et al. · The EMBO Journal · 1989 · 930 citations · Full text

Medicine, Dermatology, Molecular Biology +13

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

Leszek K. Borysiewicz, Alison Fiander, M. Nimako et al. · The Lancet · 1996 · 530 citations

Life Sciences, Infectious Diseases, Oncology +15

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

Edward C. Goodwin, Daniel DiMaio · Proceedings of the National Academy of Sciences · 2000 · 449 citations

Medicine, Cell Biology, Oncology +17